AXGN – AxoGen, Inc.
AXGN — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
6.01
Margin Of Safety %
Put/Call OI Ratio
0.29
EPS Next Q Diff
0.43
EPS Last/This Y
0.88
EPS This/Next Y
0.24
Price
30.98
Target Price
40.8
Analyst Recom
1.27
Performance Q
-2.42
Upside
-138.4%
Beta
1.03
Ticker: AXGN
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | AXGN | 29.25 | 0.33 | 0.28 | 1204 |
| 2026-03-10 | AXGN | 30.85 | 0.35 | 1.57 | 1188 |
| 2026-03-11 | AXGN | 32.15 | 0.36 | 0.14 | 1203 |
| 2026-03-12 | AXGN | 31.74 | 0.36 | 0.03 | 1202 |
| 2026-03-13 | AXGN | 31.76 | 0.36 | 0.03 | 1202 |
| 2026-03-17 | AXGN | 32.76 | 0.35 | 0.08 | 1246 |
| 2026-03-18 | AXGN | 30.94 | 0.35 | 4.00 | 1242 |
| 2026-03-19 | AXGN | 31.13 | 0.36 | 0.75 | 1247 |
| 2026-03-20 | AXGN | 30.82 | 0.35 | 0.22 | 1243 |
| 2026-03-23 | AXGN | 31.73 | 0.30 | 1.50 | 975 |
| 2026-03-24 | AXGN | 32.59 | 0.30 | 1.50 | 975 |
| 2026-03-25 | AXGN | 33.31 | 0.30 | 0.00 | 978 |
| 2026-03-26 | AXGN | 32.24 | 0.30 | 999.99 | 979 |
| 2026-03-27 | AXGN | 31.29 | 0.30 | 0.67 | 980 |
| 2026-03-30 | AXGN | 31.35 | 0.30 | 0.08 | 980 |
| 2026-03-31 | AXGN | 33.13 | 0.30 | 0.05 | 983 |
| 2026-04-01 | AXGN | 33.56 | 0.29 | 3.00 | 1011 |
| 2026-04-02 | AXGN | 34.45 | 0.30 | 0.07 | 1016 |
| 2026-04-06 | AXGN | 32.61 | 0.29 | 15.94 | 1033 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | AXGN | 29.24 | 428.6 | - | 0.50 |
| 2026-03-10 | AXGN | 30.67 | 428.6 | - | 0.50 |
| 2026-03-11 | AXGN | 32.27 | 428.6 | - | 0.50 |
| 2026-03-12 | AXGN | 31.74 | 391.7 | - | 0.50 |
| 2026-03-13 | AXGN | 32.33 | 391.7 | - | 0.52 |
| 2026-03-17 | AXGN | 32.78 | 450.0 | - | 0.52 |
| 2026-03-18 | AXGN | 30.94 | 450.0 | - | 0.52 |
| 2026-03-19 | AXGN | 31.16 | 450.0 | - | 0.52 |
| 2026-03-20 | AXGN | 30.82 | 450.0 | - | 0.52 |
| 2026-03-23 | AXGN | 31.75 | 450.0 | - | 0.52 |
| 2026-03-24 | AXGN | 32.60 | 450.0 | - | 0.52 |
| 2026-03-25 | AXGN | 33.31 | 450.0 | - | 0.52 |
| 2026-03-26 | AXGN | 32.24 | 450.0 | - | 0.52 |
| 2026-03-27 | AXGN | 31.28 | 450.0 | - | 0.52 |
| 2026-03-30 | AXGN | 31.33 | 450.0 | - | 0.52 |
| 2026-03-31 | AXGN | 33.15 | 457.2 | - | 0.52 |
| 2026-04-01 | AXGN | 33.58 | 457.2 | - | 0.52 |
| 2026-04-02 | AXGN | 34.46 | 457.2 | - | 0.52 |
| 2026-04-06 | AXGN | 32.63 | 457.2 | - | 0.54 |
| 2026-04-07 | AXGN | 30.98 | 457.2 | - | 0.54 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | AXGN | -32.82 | 3.71 | 5.36 |
| 2026-03-10 | AXGN | -32.82 | 3.71 | 5.36 |
| 2026-03-11 | AXGN | -32.82 | 3.71 | 5.69 |
| 2026-03-12 | AXGN | -32.82 | 3.71 | 5.69 |
| 2026-03-13 | AXGN | -32.82 | 3.71 | 5.69 |
| 2026-03-17 | AXGN | -32.76 | 3.72 | 5.69 |
| 2026-03-18 | AXGN | -33.00 | 3.72 | 5.69 |
| 2026-03-19 | AXGN | -33.00 | 3.72 | 5.69 |
| 2026-03-20 | AXGN | -33.00 | 3.72 | 5.69 |
| 2026-03-23 | AXGN | -33.00 | 3.71 | 5.69 |
| 2026-03-24 | AXGN | -33.00 | 3.71 | 5.69 |
| 2026-03-25 | AXGN | -33.00 | 3.71 | 6.01 |
| 2026-03-26 | AXGN | -33.00 | 3.71 | 6.01 |
| 2026-03-27 | AXGN | -33.00 | 3.71 | 6.01 |
| 2026-03-30 | AXGN | -33.00 | 3.71 | 6.01 |
| 2026-03-31 | AXGN | -33.00 | 3.71 | 6.01 |
| 2026-04-01 | AXGN | -33.00 | 3.71 | 6.01 |
| 2026-04-02 | AXGN | -33.00 | 3.71 | 6.01 |
| 2026-04-06 | AXGN | -33.00 | 3.69 | 6.01 |
| 2026-04-07 | AXGN | -31.51 | 3.69 | 6.01 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.28
Avg. EPS Est. Current Quarter
0.07
Avg. EPS Est. Next Quarter
0.15
Insider Transactions
-31.51
Institutional Transactions
3.69
Beta
1.03
Average Sales Estimate Current Quarter
57
Average Sales Estimate Next Quarter
66
Fair Value
Quality Score
53
Growth Score
58
Sentiment Score
80
Actual DrawDown %
14
Max Drawdown 5-Year %
-84.6
Target Price
40.8
P/E
Forward P/E
41.39
PEG
0.83
P/S
7.14
P/B
11.35
P/Free Cash Flow
EPS
-0.34
Average EPS Est. Cur. Y
0.54
EPS Next Y. (Est.)
0.77
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-6.97
Relative Volume
0.99
Return on Equity vs Sector %
-39.6
Return on Equity vs Industry %
-24
EPS 1 7Days Diff
EPS 1 30Days Diff
0.04
EBIT Estimation
◆
AXGN
Healthcare
$30.99
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
45
Range 1M
47.7%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
81.5%
EPS NY
42.3%
52W%
81%
Long-Term Value
Quality companies, undervalued
WEAK
🔴 SELL
-0.2% upside
Upside
-0.2%
Quality
53
AxoGen, Inc.Sector: Healthcare
Industry: Medical Devices
Employees: 622
Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product used to protect and wrap damaged peripheral nerves and reinforce reconstructed nerve gaps. It also provides Axoguard HA+ Nerve Protector, a surgical implant for non-constricting protection of the peripheral nerves; Axoguard Nerve Cap, a porcine submucosa ECM product; Avive+ Soft Tissue Matrix, a multi-layer amniotic membrane allograft; and Avance Method, a technique to process Avance Nerve Graft from donated human peripheral nerve tissue. In addition, the company offers peripheral nerve tissue recovery and acquisition, and testing, as well as donor medical review and release, debridement and other processing steps, packaging, and sterilization. It provides its products to hospitals, surgery centers and military hospitals, calling on surgeons, including plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and certain oral and maxillofacial surgeons through independent in-country distributors. The company is headquartered in Alachua, Florida.
AXGN
Latest News
—
Caricamento notizie per AXGN…
stock quote shares AXGN – AxoGen, Inc. Stock Price stock today
news today AXGN – AxoGen, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch AXGN – AxoGen, Inc. yahoo finance google finance
stock history AXGN – AxoGen, Inc. invest stock market
stock prices AXGN premarket after hours
ticker AXGN fair value insiders trading